This website is intended for healthcare professionals only.
Prof. Gerald Prager
MD, PHD
DIRECTOR OF THE GI CANCER PROGRAM OF THE DEPARTMENT OF MEDICAL ONCOLOGY, MEDICAL UNIVERSITY OF VIENNA AND COMPREHENSIVE CANCER CENTER, VIENNA
About Our Speaker
Prof Prager is the Director of the GI Cancer Program of the Department of Medical Oncology at the Medical University of Vienna and Comprehensive Cancer Center, Vienna. He leads the Unit for Precision Medicine in Cancer and is an Associate Professor of Medicine, Board Certified for Internal Medicine, Hematology, and Medical Oncology. Prof Prager graduated from the Medical School of the University of Vienna and completed his postdoctoral training at the University of California, San Diego, USA and was a Visiting Professor at the Norris Cancer Center, University of Southern California, Los Angeles, USA in 2011. Prof Prager’s main research interests focus on translational research and (tumor-) angiogenesis and his work was honored by more than 20 international awards and published in highly renowned international journals. Prof Prager is also a member of the ESMO Scientific Committee.
Related Webinars
Continuum of care in mPaCa Which strategy for our patients
Treatment lanscape and strategies in mPaCa
Treatment strategy in mPaCa: extending the continuum of care?
Treatment planning in mPaCa optimizes and extends the continuum of care
Personalized treatment to maximize outcomes for patients with CCA
Precision medecine opens up the possibility of targeted therapies to optimize CCA patients outcomes.
Redefining 3l mCRC landscape with the arrival of combination therapies
This webinar focuses on combination therapies in mCRC treatment – to optimize overall survival and improve patients’ quality of life.
Advances in mPaCa care:
Treatment decision-making in 1L
This webinar focuses on treatment decision-making in 1L mPDAC.
